4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050143
Options or other derivatives
- PRESIDENT & CFO acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MORTIMER IAN PRESIDENT & CFO | 2019-09-16 | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…